Patents by Inventor Joe-Elie SALEM

Joe-Elie SALEM has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • METHOD FOR TREATING IMMUNE TOXICITIES INDUCED BY IMMUNE CHECKPOINT INHIBITORS
    Publication number: 20230293531
    Abstract: The invention relates to the use of a JAK inhibitor for treating or preventing adverse events in patient treated with an immune checkpoint inhibitor, or for treating cancer in combination with an immune checkpoint inhibitor.
    Type: Application
    Filed: July 29, 2021
    Publication date: September 21, 2023
    Inventors: Yves ALLENBACH, Joe-Elie SALEM, Céline ANQUETIL
  • Steroidal hormones for the treatment and prevention of wave burst arrhythmia
    Patent number: 11666584
    Abstract: The invention relates to a new method for the prevention and treatment of wave burst arrhythmia by administering a gestagen having an androgenic effect.
    Type: Grant
    Filed: April 18, 2017
    Date of Patent: June 6, 2023
    Assignees: ASSISTANCE PUBLIQUE—HOPITAUX DE PARIS, INSTITUT NATIONAL DE LA SANTÉ ET DE LA RECHERCHE MEDICALE (INSERM), SORBONNE UNIVERSITÉ
    Inventors: Joe-Elie Salem, Christian Funck-Brentano, Anne Bachelot, Xavier Waintraub
  • METHOD FOR DETECTING RISK OF TORSADES DE POINTES
    Publication number: 20220230758
    Abstract: The invention relates to methods and devices for the detection and prediction of the risk for a patient to have a torsade de pointe event, and causes thereof, in particular via the use of neural networks.
    Type: Application
    Filed: June 4, 2020
    Publication date: July 21, 2022
    Inventors: Joe-Elie SALEM, Edi PRIFTI, Alfredo Aram PULINI, Jean-Daniel ZUCKER, Christian FUNCK-BRENTANO, Antoine LEENHARDT, Isabelle DENJOY, Fabrice EXTRAMIANA
  • METHOD FOR TREATING CHECKPOINT INHIBITORS INDUCED ADVERSE EVENTS
    Publication number: 20220125880
    Abstract: The invention relates to the use of CTLA4 agonist for treating or preventing adverse events in patient treated with an immune checkpoint inhibitor.
    Type: Application
    Filed: February 3, 2020
    Publication date: April 28, 2022
    Inventors: Joe-Elie SALEM, Yves ALLENBACH, Mathieu KERNEIS, Javid MOSLEHI, Douglas JOHNSON
  • METHOD FOR DIAGNOSIS AND TREATING PERIPHERAL NEUROPATHIES
    Publication number: 20220011323
    Abstract: The present invention relates to MGP as a new serum marker useful by itself or in combination with other markers for diagnosis of peripheral neuropathies, in particular in diabetic patients. The invention is also drawn to diagnosis kits for the implementation of this method.
    Type: Application
    Filed: November 14, 2019
    Publication date: January 13, 2022
    Inventors: Olivier BOURRON, Joe-Elie SALEM, Agnès HARTEMANN
  • Method for determining the likelihood of torsades de pointes being induced
    Patent number: 11071488
    Abstract: The present invention relates to the field of cardiology and, more specifically, to a novel algorithm that can be used, in particular, in a method for determining if a drug is likely to induce a cardiac ventricular repolarisation disturbance, based on variations in electrocardiogram data.
    Type: Grant
    Filed: April 12, 2017
    Date of Patent: July 27, 2021
    Assignees: ASSISTANCE PUBLIQUE—HOPITAUX DE PARIS, INSTITUT NATIONAL DE LA SANTÉ ET DE LA RECHERCHE MÉDICALE (INSERM), SORBONNE UNIVERSITÉ
    Inventors: Joe-Elie Salem, David-Alexandre Tregouet, Jean-Sébastien Hulot, Christian Funck-Brentano, Marine Germain
  • STEROIDAL HORMONES FOR THE TREATMENT AND PREVENTION OF WAVE BURST ARRHYTHMIA
    Publication number: 20200352960
    Abstract: The invention relates to a new method for the prevention and treatment of wave burst arrhythmia by administering a gestagen having an androgenic effect.
    Type: Application
    Filed: April 18, 2017
    Publication date: November 12, 2020
    Inventors: Joe-Elie SALEM, Christian FUNCK-BRENTANO, Anne BACHELOT, Xavier WAINTRAUB
  • METHOD FOR DETERMINING THE LIKELIHOOD OF TORSADES DE POINTES BEING INDUCED
    Publication number: 20190059764
    Abstract: The present invention relates to the field of cardiology and, more specifically, to a novel algorithm that can be used, in particular, in a method for determining if a drug is likely to induce a cardiac ventricular repolarisation disturbance, based on variations in electrocardiogram data.
    Type: Application
    Filed: April 12, 2017
    Publication date: February 28, 2019
    Inventors: Joe-Elie SALEM, David-Alexandre TREGOUET, Jean-Sébastien HULOT, Christian FUNCK-BRENTANO, Marine GERMAIN